Intake
DRAFT v0.4
· autosaved 2m ago
25h → 2h
Saved on this RFP
EP
SN
JO
3 live
SHOW FLAGGED ONLY
Export
Submit bid
Krux recommendation
Recommend bid · BX-3142
High confidence
Capability fit
94%
vs. RFP requirements
Win probability
38%
vs. competitive set
Predicted margin
31%
incl. Aib coupling premium
Estimated value
$2.4M
fixed-fee program
Reasoning · 4 grounded factors
92
Synthesis route confidence
, TCG has 4 SPPS peptide programs ≥30 residues. Avg yield 17% vs. industry 12–14%.
kb-3
86
Capacity availability
, Reactor train R-201/R-208 has 14 weeks open Aug–Nov 2026.
kb-2
88
Competitive pricing intel
, GLP-1 analog peptides at this scale price $1.8–2.6M. Don't go below $1.7M.
kb-a-4
86
Sponsor pattern
, Phase 2 biotechs evaluate timeline reliability over price.
kb-a-5
2 capability claims need senior validation
before submission, see flagged sentences in the draft below.
Section · 1 of 5
Executive Summary
4 sentences ·
3 grounded
· 1 flagged
Krux is drafting · click to skip